Please click here to obtain permission to reproduce this image.

Click on image to view larger version.


Figure 3


Figure 3 Use percentage of patients showing a ≥6 mEq/l increase in serum sodium or normal serum sodium at the end of intravenous conivaptan (CNV) treatment. *p = 0.0359; {dagger}p = 0.0025; {ddagger}p = 0.032; §p = 0.0023 vs. placebo from Cochran-Mantel-Haenszel test. Adapted with permission (8). HF = heart failure.